Exousia Bio, Inc. (LMMY) Total liabilities 2023–2025
Exousia Bio, Inc. (LMMY) total liabilities at each fiscal year-end, per SEC filings.
$0FY2025 · since FY2023: $66,132 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $82,348 | +24.5% |
| FY2023 | $66,132 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LMMY financial trends
LMMY RevenueLMMY Net incomeLMMY Net marginLMMY Gross profitLMMY Gross marginLMMY Operating incomeLMMY Operating marginLMMY Operating cash flowLMMY Free cash flowLMMY Capital expendituresLMMY Return on equityLMMY Stock buybacksLMMY Dividends paidLMMY Total assetsLMMY Shareholders’ equityLMMY overview →